Molecular Differences between Ductal Carcinoma In Situ and Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study

Mostrar otras versiones (1)

Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. Although DCIS is generally highly curable, some women with DCIS will develop life-threatening invasive breast cancer, but the determinants of progression to infiltrating ductal cancer (IDC) ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Moelans, Cathy B., de Weger, Roel A., Monsuur, Hanneke N., Maes, Anoek H. J., van Diest, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2010
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605452/
https://www.ncbi.nlm.nih.gov/pubmed/20978320
http://dx.doi.org/10.3233/ACP-CLO-2010-0546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605452/
https://www.ncbi.nlm.nih.gov/pubmed/20978320
http://dx.doi.org/10.3233/ACP-CLO-2010-0546

Ejemplares similares